Fmoc-Gly-CHN2

Fmoc-Gly-CHN2 is an N-Fmoc protected glycine hydrazide derivative bearing a terminal diazomethyl functionality (CHN2) that serves as a reactive diazo group precursor while retaining the amino acid backbone for peptide-compatible chemistry. The molecule combines a stereochemically non-chiral glycine core with an Fmoc carbamate that can be removed under base to expose the primary amine for subsequent amide bond formation. The diazomethyl (diazo) moiety introduces controlled reactivity toward insertion, cyclopropanation, and carbene-transfer pathways, enabling downstream conversion into diverse carbon-carbon and carbon-heteroatom frameworks. The presence of a protected amine and a latent diazo functionality makes Fmoc-Gly-CHN2 a chiral-synthesis-adjacent but stereochemically simple building block that can be handled as a peptide-grade intermediate and then transformed into functionalized amino acid or peptidomimetic motifs.

1. Peptide Synthesis

Fmoc-Gly-CHN2 supports solid-phase peptide synthesis workflows where the Fmoc-protected glycine amine participates in standard coupling chemistry after Fmoc deprotection. The glycine backbone provides a minimal side chain that can be incorporated as a spacer or linker residue, while the CHN2 diazo group can be retained through peptide assembly and then converted post-coupling to introduce new functional handles. The diazo functionality can function as a masked reactivity site for subsequent scaffold diversification of the peptide or peptidomimetic. Resulting products include diazo-functionalized peptide fragments and amino acid-derived linkers used for structure-activity relationship studies and chemical biology probes.

2. Peptidomimetics Construction

Fmoc-Gly-CHN2 enables peptidomimetic construction by combining a peptide-compatible glycine unit with a diazo-bearing carbon that can be transformed into carbene-derived motifs. The Fmoc carbamate strategy allows orthogonal handling: the protected amine supports controlled incorporation into peptide analogs, while the diazo group provides a downstream transformation point for generating cyclized or inserted structures. Diazo-derived intermediates can be used to create constrained conformations, introduce reactive electrophilic centers, or install functional groups that mimic side-chain chemistry beyond native amino acids. Peptidomimetic libraries prepared from this intermediate can be applied in molecular design campaigns where backbone modifications and side-chain surrogates are used to tune binding and reactivity profiles.

3. Chemical Biology Labeling

Fmoc-Gly-CHN2 can be applied in chemical biology labeling strategies that require incorporation of a diazo precursor into amino acid frameworks for subsequent bioorthogonal-style transformations. The protected amine and peptide building block character allow attachment to peptide carriers, targeting motifs, or scaffold peptides, while the terminal diazomethyl diazo group can be converted into reactive intermediates for conjugation to biomolecule-compatible partners. The glycine residue simplifies synthesis of labeled conjugates by minimizing steric effects and supporting modular assembly. Downstream derivatives can be used to generate diazo-derived probes for mapping reaction pathways, studying biomolecular interactions, or producing labeled standards for analytical research.

4. Process Chemistry Intermediate

Fmoc-Gly-CHN2 serves as a process-relevant intermediate for fine chemical synthesis routes that require an Fmoc-protected amino acid equivalent combined with a diazo functionality. The Fmoc group provides a robust protection strategy for the primary amine during multi-step manufacturing sequences, enabling sequential operations such as peptide-fragment assembly, purification, and later functional-group activation. The diazo (CHN2) moiety can be leveraged as a controlled intermediate that feeds into downstream carbene-transfer transformations to access substituted building blocks used in medicinal chemistry and specialty chemical production. The resulting material stream supports scalable preparation of diazo-containing amino acid derivatives and functionalized linkers used across applied synthetic campaigns.

5. Analytical Research Standards

Fmoc-Gly-CHN2 can be utilized for analytical research and method development where diazo-containing amino acid derivatives are required as reference materials or derivatization reagents. The Fmoc-protected glycine framework supports reproducible synthesis of defined peptide-like structures, while the CHN2 group provides a distinct chemical signature that can aid detection by LC-MS and related analytical workflows after conversion to characteristic products. Diazo-derived transformation products can serve as calibration or confirmation standards for monitoring diazo chemistry in complex mixtures. Analytical studies benefit from the clear separation between protected-amino acid handling and later diazo activation, supporting robust characterization of amino acid derivatization and peptide-coupling intermediates.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis